Skip to Main Content

INFORMATION FOR

    Stuart Seropian, MD

    Professor of Internal Medicine (Hematology)
    DownloadHi-Res Photo

    Are You a Patient?

    View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

    View Doctor Profile

    Additional Titles

    Acting Director, Stem Cell Transplantation

    Chairman, Car-T Cell Joint Steering Committee

    Director, Unrelated Donor Transplant Program, Stem Cell Transplantation

    Co-Director, Immune Effector Cell Therapy

    Co-Director, Adult CAR T-Cell Therapy Program

    Contact Info

    Yale Cancer Center

    PO Box 208028, 333 Cedar Street, TMP 3

    New Haven, CT 06520-8028

    United States

    About

    Titles

    Professor of Internal Medicine (Hematology)

    Acting Director, Stem Cell Transplantation; Chairman, Car-T Cell Joint Steering Committee; Director, Unrelated Donor Transplant Program, Stem Cell Transplantation; Co-Director, Immune Effector Cell Therapy; Co-Director, Adult CAR T-Cell Therapy Program

    Biography

    Dr. Seropian is a Professor of Medicine in the department of Internal Medicine, Section of Hematology, Yale University School of Medicine. He received his medical degree from George Washington University School of Medicine and completed residency and fellowship training at Yale-New Haven Hospital/Yale University School of Medicine in 1996.

    Dr. Seropian serves as Interim Director of the Stem Cell Transplant Program, Co-Director, Immune Effector Cell Therapy, and Chairman, Car-T Cell Joint Steering Committee, Yale-New Haven Hospital. Dr. Seropian’s research interests include methods to improve the outcomes of transplantation through use of novel anti-cancer agents and new methods of treating graft versus host disease

    Appointments

    Other Departments & Organizations

    Education & Training

    Resident
    Yale-New Haven Hospital (1994)
    Intern
    Yale-New Haven Hospital (1992)
    MD
    George Washington University (1991)
    BS
    Tufts University (1984)

    Research

    Overview

    Medical Research Interests

    Bone Marrow Transplantation; Clinical Trials, Phase III as Topic; Hematologic Diseases; Hematopoietic Stem Cells; Hodgkin Disease; Leukemia; Lymphocytes; Lymphoma; Lymphoma, Non-Hodgkin; Plasma Cells

    Public Health Interests

    Clinical Trials; Cancer

    Research at a Glance

    Yale Co-Authors

    Frequent collaborators of Stuart Seropian's published research.

    Publications

    2024

    Clinical Trials

    Academic Achievements & Community Involvement

    • activity

      Advisory Board

    • activity

      Bone Marrow Transplantation

    • activity

      Transfusion

    • activity

      Hodgkin’s Lymphoma Guidelines Panel, National Comprehensive Cancer Center Network

    • activity

      EMR User Group, Center for International Blood and Marrow Transplantation Research (CIBMTR)

    Clinical Care

    Overview

    Stuart Seropian, MD, is a medical oncologist who specializes in treating patients with blood cancers, including acute and chronic leukemia, non-Hodgkin’s lymphoma, and multiple myeloma. Dr. Seropian also sees patients with non-cancerous bone marrow disorders, including aplastic anemia. He is director of the adult Stem Cell Transplant program and co-director of the CAR T-cell Therapy Program for adults.

    In medical school, Dr. Seropian enjoyed studying the biology of cancer and wanted to provide long-term patient care, which led to his pursuing medical oncology. “I have patients who see me as their primary care physician—as the doctor most responsible for their long-term care,” Dr. Seropian says. “Patients will say they’ve experienced a physician who had one foot out the door before all questions were answered. But the relationship with the patient is vital for cancer treatment.”

    During his career, Dr. Seropian has witnessed treatment options for patients with blood cancers improve by leaps and bounds, from chemotherapy to the personalized CAR T-cell and stem cell transplantation therapies.

    “The general view among the public is that cancer is terminal,” Dr. Seropian says. “People are always surprised to hear that cure rates [for certain cancers] range from 30 to 65 percent.”

    He points out that a transplant physician is one of many providers of care in a large cast, which includes other physician subspecialists, nurse practitioners, nurses, coordinators, laboratory physicians and technicians. “Patients who come here are cared for by a family of people,” he says.

    Dr. Seropian is an associate professor of medicine (hematology) at Yale School of Medicine.

    Clinical Specialties

    Hematologic Oncology; Leukemia & Lymphoma; Hematology

    Fact Sheets

    Yale Medicine News

    Get In Touch

    Contacts

    Appointment Number
    Clinic Fax Number
    Mailing Address

    Yale Cancer Center

    PO Box 208028, 333 Cedar Street, TMP 3

    New Haven, CT 06520-8028

    United States

    Locations

    • Patient Care Locations

      Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.